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Size dependent
Dose dependentIt is well known that delivery efficiency to cells is highly dependent on particle size and the administered
dose. However, there is a marked discrepancy in many reports, mainly due to the inconsistency in assess-
ment of various parameters. In this particular research, we designed experiments using layered double
hydroxide nanoparticles (LDH NPs) to specifically elucidate the effect of particle size, dose and dye load-
ing manner on cellular uptake. Using the number of LDH NPs taken up by HCT-116 cells as the indicator
of delivery efficiency, we found that (1) the size of sheet-like LDH in the range of 40–100 nm did not
significantly affect their cellular uptake; (2) cellular uptake of 40 and 100 nm LDH NPs was increased
proportionally to the number concentration below a critical value, but remained relatively constant
beyond the critical value; and (3) the effect of the dye loading manner is mainly dependent on the loading
capacity or yield. In particular, the loading capacity is determined by the NP specific surface area. This
research may be extended to a larger size range to examine the size effect, but suggests that it is
necessary to set up a protocol to evaluate the effects of NP’s physicochemical properties on the cellular
delivery efficiency.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Recent years have witnessed the enormous progress of nano-
sized materials applied for drug/gene delivery, which include var-
ious polymeric nanoparticles (NPs), liposomes, metal (such as gold)
and metal oxide (such as iron oxide, IO) NPs, mesoporous silica NPs
(MSNs), carbon nanotubes (CNTs), layered double hydroxide (LDH)
NPs, and their hybrids etc. [1–16].
It is well known that the physicochemical properties, such as NP
size, shape, dose and surface charge, affect NP delivery efficacy. Of
these characteristics, the particle size is a crucial factor which
determines NP endocytosis pathway [17,18], uptake rate and effi-
ciency [6,16,19–22], in vitro cytotoxicity [23–28], immune
responses [27–30], and the final localisation [15,31,32]. Thus
size-dependent uptake of various NPs has been intensively investi-
gated and widely reported. For example, for organic NPs, some
researchers claimed smaller NPs resulted in higher cellular uptake
[22,33], while others reported an optimal size range for highest
uptake [34–37]. Ross and Hui [38] even found linearly increasingcellular uptake of lipoplex in the size range of 35–2200 nm. For
inorganic-based NPs, similar results were reported. Some research-
ers reported an optimal particle size for uptake of Au NPs, CNTs,
and MSNs (50 nm) [6,39–41], but some others found smaller
Au, silica, and IO NPs had improved cellular uptake than larger
ones in a certain size range [42–45].
Besides particle size, NP shape, on the other hand, also affects
cellular uptake behaviour. Chithrani et al. [6] reported HeLa cell
took up much more spherical Au NPs than rod-shaped Au NPs with
a high aspect ratio. Jin et al. [40] found long and short SWNTs
showed lower cellular uptake than those with the medium length.
Choi and Choy’s group studied the cellular uptake behaviours and
mechanisms of LDH NPs (with sheet-like shape), finding 50 nm
LDH NPs showed higher cellular uptake than 100–200 nm and
350 nm ones [46,47]. Recently we found 40 nm LDH NPs can carry
1–4 times more dsDNA than 100 nm ones at LDH:DNA mass ratio
of 1:1 and 5:1, contributing to enhanced gene delivery [48,49].
In brief, the observations and conclusions differ from research
groups, especially the particle size effect, being not so consistent
and sometimes confused. This could be caused by several vague
parameters without clear and consistent definition. The first one
is NP size, which is normally characterised as the Z-average hydro-
dynamic diameter (measured by light scattering technology)
[29,41,50] or the number average size (measured and statistically
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dose of nanoparticle. Some have used the mass concentration
while others used the particle number concentration. The third
one is the delivery efficiency, often expressed as the NP number
[6,16,43,51], the mass amount (pg/cell) [16,41], or the relative
amount of labelled fluorescence dye [48,52] taken up by each cell.
In addition, the difference in the shape and surface property from a
variety of materials and surface modified functional groups may
also cause the inconsistency. It is worth noting that the differing
cell types used may also contribute to the inconsistency in deter-
mining the optimal particle size for the maximum cellular uptake
efficiency.
Therefore, this particular research aimed to clearly elucidate
effects of particle size (Z-average), dose (particle number concen-
tration) and the dye loading (bulky or surface) of sheet-like LDH
NPs on the uptake efficiency by HCT-116 cells. We found that (1)
the cellular uptake efficiency of 40–50 nm NPs was similar to that
of 90–100 nm NPs; (2) there was a critical particle number
concentration, below which cellular uptake was in linear propor-
tion to the particle number concentration, while beyond which
cellular uptake was not improved; (3) dye loading on the surface
may also affect cellular uptake depending on the surface loading
capacity.2. Experimental
2.1. LDH NPs preparation
Small LDH (sLDH) NPs were prepared by a non-aqueous precip-
itation method [48,49]. Briefly, 10 mL methanol (Fluka, P99.0%)
solution containing 6 mmol of Mg(NO3)26H2O and 2 mmol of
Al(NO3)39H2O (Fluka, >99.0%) was added drop-wise to a 40 mL
solution of methanol containing 16 mmol NaOH (Fluka, >97.0%,
pellets) under vigorous stirring. The precipitate slurry was col-
lected via centrifugation, then redispersed in 40 mL fresh methanol
and transferred to a Teflon-lined autoclave for heat-treatment at
100 C for 4 h. The final LDH slurry was collected and manually dis-
persed in 40 mL of deionised water after washing twice with
deionised water. This dispersion resulted in a homogeneous sLDH
suspension after 4–6 days with a sLDH mass concentration of 6–
7 mg/mL.
Large LDH (L-LDH) NPs were synthesised by mixing 10 mL of
aqueous solution containing 3.0 mmol of MgCl26H2O and
1.0 mmol of AlCl36H2O (Sigma–Aldrich, 99.0–102.0%) with
40 mL of 0.15 M NaOH solution and vigorously stirred for
10 min at room temperature [53,54]. The LDH slurry was col-
lected by centrifugation, washed twice with deionised water
(40 mL), and then resuspended in deionised water (40 mL). The
suspension was then transferred to a Teflon-lined autoclave
and hydrothermally treated at 100 C for 16 h. The suspension
contained approximately 4 mg/mL of homogeneously dispersed
L-LDH NPs.
Both small and large LDH-FITC NPs were prepared by the ion-
exchange method. Here, FITC (fluorescein isothiocyanate isomer I,
Sigma–Aldrich) sodium solution (0.05 or 0.01 mmol) was mixed
with 1 mmol of either sLDH or L-LDH slurry and then shaken on
a reciprocal shaker for 1 h. After ion-exchange, the unchanged FITC
and residual sodium nitrate or sodium chloride (NaNO3/NaCl) were
separated. The collected slurry was then redispersed in deionised
water and subjected to 2–4 h of hydrothermal and sterilisation
treatment.
All NP sizes were determined by dynamic light scattering (DLS,
Zetasizer Nano ZS, Malvern Ltd). The Z-average size of sLDH was
found to be 40 nm (54 nm for sLDH-FITC), while L-LDH
measured 100 nm (90 nm for L-LDH-FITC).2.2. Suspension stability test
LDH NPs were diluted by complete cell culture media (10% v/v)
of foetal bovine serum (Gibco) mixed with Dulbecco’s Modified
Eagle Medium (DMEM, with L-glutamine and 4.5 g/L of glucose,
Gibco)) at desired concentrations, and then particle size distribu-
tion of the suspension mixture was measured using the Zetasizer.
2.3. Nucleic acid loading and agarose gel electrophoresis
Nucleic acids were loaded on LDH NPs by mixing LDH suspen-
sion with nucleic acid solution at the LDH:dsDNA mass ratios of
2:1, 5:1, 10:1, 20:1, and 40:1. A 2.5% agarose (molecular grade,
Bioline) gel with Gel-Red (Invitrogen™) stain was made and then
nucleic acids with/out LDH for binding were loaded in the
wells. For each well, 260 ng double stranded DNA (dsDNA DCC1,
Geneworks) was used. Gel was imaged by a Bio-Rad imaging
system after a run at 90 V for 45 min in TBE (Tris/Borate/EDTA,
Invitrogen™) buffer.
2.4. Cellular uptake
HCT-116 cells were seeded in 6-well plates at density of 1  105
cells per well in 2 mL complete cell culture media. After 24 h of
incubation, cell culture media was replaced by 1 mL of fresh media
with/out desired concentrations of LDH-FITC NPs or LDH-DNA-Cy3
NPs (40 nM DNA was used). At different time points after further
incubation (from 15 min to 8 h), the culture media was removed,
and cells were washed twice with PBS buffer (Gibco) and then
detached from the plates by trypsin–EDTA (Gibco). The cells were
washed twice with PBS buffer and then fixed in a certain volume of
2% PFA (paraformaldehyde, Chemsupply) before measurement by
flow cytometry (BD Accuri™ C6 Flow Cytometer System, band pass
filter 530/30 for detecting FITC, 585/40 for detecting Cy3, 10,000
cells were counted). All treatments were performed for three dif-
ferent batches in duplicate. Data are presented as the mean ± SEM
(standard error of the mean).3. Results
3.1. Suspension stability of sLDH and L-LDH NPs
As shown in Fig. 1A, sLDH and L-LDH NPs were well dispersed in
water, having a hydrodynamic diameter ranging from 10 to
100 nm with a Z-average size of 40 nm, and from 40 to 250 nm
with the Z-average size of 100 nm, respectively. The Z-average size
here is the intensity weighted mean hydrodynamic diameter of
particles (more details can be referred to Malvern Instruments Fre-
quently Asked Question ‘‘What is the Z-average’’). Both sLDH and
L-LDH NPs have a zeta potential of 40 mV, which is in agreement
with earlier reports for LDH [48,54,55].
When LDH NPs were diluted in complete cell culture media,
both sLDH and L-LDH NPs aggregated, and this was found to be
concentration- and size-dependent. As shown in Fig. 1B, when
the sLDH NP suspension was diluted to a concentration range of
100–800 lg/mL, sLDH formed aggregates with a Z-average size of
200–450 nm. Applying the same concentration range to L-LDH
NPs, they also aggregated but to a lesser extent, with a Z-average
size of 180–300 nm. The Z-average size (74 and 107 nm) was in
close agreement with that in the original suspension for both sLDH
and L-LDH when they were further diluted to 40 lg/mL (Fig. 1B).
The aggregation may affect the cellular uptake as Andersson
et al. [56] found NP uptake was strongly dependent on the agglom-
eration size, not the primary particle size. This proved serendipi-
tous as the concentration of LDH NPs used in cellular uptake
Fig. 1. Particle sizes of sLDH and L-LDH NPs in water and complete cell culture
media at different concentrations (⁄MS = medium + serum, i.e. the complete cell
culture medium).
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unwanted NP aggregation.
Particle aggregation was more pronounced with sLDH in the
culture media and this could be attributed to their relative dimen-
sions compared to L-LDH. sLDH possesses a surface area 2.5 times
that of L-LDH NPs, and thus its capacity to adsorb proteins (a key
driver of aggregation) present in cell culture media is also consid-
ered to be 2.5-fold greater than L-LDH. Upon lowering the NP con-
centration sufficiently (i.e. to <40 lg/mL), sLDH and L-LDH NPs
adsorb protein until they reach a relative state of equilibrium, at
which point their surface properties are dictated by adsorbed pro-
teins such that aggregation is suppressed. That said, at high NP
concentrations, one can expect to reach a point where all available
proteins are adsorbed by the NPs, and this triggers surface
adsorbed proteins to reach out and form protein-bridges with
neighbouring particles, resulting in aggregation. This latter
phenomenon is likely to be more of an issue with sLDH, as L-LDH
possesses a smaller surface area and so is able to accommodate
far less protein.3.2. Gene loading
Fig. 2 shows the electrophoretic mobility of dsDNA loaded onto
LDH NPs at increasing LDH:dsDNA mass ratios. The first lane for
each gel represents a 21–25 bp dsDNA marker, and the bright
bands towards the bottom of the gels are free dsDNA. As can be
seen in Fig. 2A, sLDH NPs completely immobilised dsDNA at the
mass ratio of P5:1 in water, while at 2:1 some free dsDNA was
present. Similarly, L-LDH NPs completely bound dsDNA at the mass
ratio ofP10:1 in water, while the binding was not complete at 5:1
(Fig. 2C). This difference can again be attributed to the particle size
as the larger surface area of sLDH NPs can accommodate a greater
load of dsDNA as compared to L-LDH NPs at the equivalent mass
concentration.
When the LDH-dsDNA complexes were assessed in complete
cell culture media, electrophoretic studies revealed less dsDNA
immobilised (Fig. 2B and D) than that in water (Fig. 2A and C). In
the complete cell culture media, only at mass ratios of 20:1 and40:1 was dsDNA observed to be completely bound by both sLDH
and L-LDH NPs. However, the surface area of the respective NPs
again yielded subtle differences in binding with dsDNA at the
lower (e.g. 5:1) mass ratios.
As alluded to earlier, the significant differences in mass ratios
necessary to completely immobilise dsDNA in water versus com-
plete cell culture media can once again be attributed to the com-
petitive adsorption of proteins (in serum) onto the respective NP
surfaces. This competition results in a relatively higher mass of
LDH NPs needed to fully complex dsDNA in complete cell culture
media, and is a phenomenon seen with other vector-DNA complex-
ation studies [57].
3.3. Cellular uptake kinetics of LDH-FITC NPs
3.3.1. Dose-dependent uptake
We first tested the cellular uptake of FITC-labelled NPs at
different LDH concentrations by HCT-116 cells. The FITC loading
capacity within both types of LDH NPs was comparable, being 5%
of all intercalated anions (denoted as LDH-5%FITC). We found that
>99% of cells were FITC-positive after incubation with either
sLDH-5%FITC or L-LDH-5%FITC at 4 h, and across the concentra-
tions measured (2.5–20 lg/mL) (Fig. 3A and B). The mean fluores-
cence intensity of cells treated with sLDH-5%FITC at these
concentrations did not change (P5.0 lg/mL), indicating that
cellular uptake was saturated under these conditions. Our previous
confocal images have confirmed that hexagonal LDH NPs are taken
up by various cell types and are mostly located in the cytoplasm
[48,54,58,59].
In sharp contrast, the mean fluorescence intensity of cells trea-
ted with L-LDH-5%FITC exhibited increasing fluorescence intensity
as the LDH concentration was raised (Fig. 3C); this reveals that the
cellular uptake of L-LDH-5%FITC continued under the same condi-
tions albeit at a declining rate, indicating the saturated particle
concentration for L-LDH-5%FITC is most likely in the region of
20 lg/mL. For sLDH, at the concentration of 1.4 lg/mL, the mean
fluorescence intensity was quite low, showing a strong depen-
dence on the sLDH mass concentration, similar to the dependence
seen by L-LDH at 2.5–20 lg/mL (Fig. 3C). Choy et al. [11] also found
dose dependent uptake of LDH-FITC NPs by NIH 3T3 cells in the
test concentration range (<45 lM). Li et al. [50] reported concen-
tration dependent uptake of 65 nm CO3LDH-FITC by NSC 34 cells
in the concentration range of 6.25–100 lg/mL, where FITC was
adsorbed onto the surface of CO3-LDH instead of intercalated into
the interlayers.
3.3.2. Time-dependent uptake
To explore LDH-5%FITC cell uptake kinetics, time-dependent
uptake of small and large LDH-5%FITC at 1.4 and 10.0 lg/mL was
investigated. Fig. 4A shows that almost all cells treated with
1.4 lg/mL of L-LDH-5%FITCwere FITC-positive afterP2 h, although
the mean FITC fluorescence intensity kept increasing with incuba-
tion time (Fig. 4C). In comparison, only 25–35% cells were FITC-
positive with the mean FITC fluorescence intensity nearly constant
when treated with sLDH-FITC at this concentration for P2 h. Of
note was that the mean fluorescence intensity of cells treated with
L-LDH was 15–20 times that of sLDH, after 2–8 h of incubation.
In the case of 10 lg/mL of FITC-labelled LDH NPs, almost all
cells were FITC-positive upon treatment with both small and large
LDH-5%FITC NPs (Fig. 4B) after 4 h of incubation. During the
15 min–4 h incubation window L-LDH-5%FITC led to a marginally
higher percentage of FITC-positive cells. This is comparable to what
Li et al. [55] reported, where 60–70% of positive cells were
observed after incubating MDDC cells with 20 lg/mL FITC-labelled
LDH NPs (hydrodynamic number size 60 nm). The mean FITC
intensity continuously increased during the whole uptake process
Fig. 2. Electrophoretic study comparing loading of dsDNA into sLDH and L-LDH NPs in the presence of water (A and C) and complete cell culture media (B and D) at increasing
mass ratios.
Fig. 3. Cellular uptake of LDH-5%FITC NPs at different concentrations by HCT-116 cells.
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Fig. 4. Time course cellular uptake of LDH-5%FITC NPs at equivalent mass
concentration by HCT-116 cells.
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LDH-FITC NPs by NIH 3T3 cells was also reported by Choy et al.
[11] Interestingly, the mean FITC fluorescence intensity of the cells
treated with 10 lg/mL of L-LDH-5%FITC appeared to be 2–3 times
that of the cells treated with 10 lg/mL of sLDH-FITC at each time
point.3.3.3. Particle size-dependent uptake
To elucidate specifically the role of NP size on the rate and effi-
ciency of cellular uptake, we particularly prepared L-LDH NPs con-
taining 1% FITC (L-LDH-1%FITC,90 nm) and compared the cellular
uptake at 20 lg/mL of L-LDH-1%FITC and 4 lg/mL of sLDH-5%FITC
(both being close to saturated particle concentration as discussed
earlier). In this series of experiments, each FITC-labelled NP con-
tained an equivalent amount of FITC and the NP number concen-
tration was also the same. Thus, assessment of cellular uptake
efficiency would be reflected purely from a NP-size perspective.
As shown in Fig. 5, similar FITC-positive cell percentage and mean
FITC intensity were observed in both cases. The subtle difference is
that cellular uptake efficiency equilibrated after 2 h of incubation
with sLDH-FITC, while L-LDH-FITC NP uptake kept increasing over
the same period, as measured by the percentage of FITC-positive
cells and mean FITC fluorescence intensity. This probably reflected
a more rapid uptake of sLDH-FITC NPs before 4 h, but sustainedFig. 5. Time course cellular uptake of sLDH-5%FITC and L-LDH-1%FITC by HCT-116
cells (at identical particle concentration and FITC loading).and continuous uptake of L-LDH-FITC NPs after 4 h. Rapid inter-
nalisation of 50 and 100 nm spheric NPs compared to 200 nm ones
was also reported by Rejman et al. [18]. More interestingly, the
continuous uptake of larger NPs was also observed and reported
for viral NPs [60], polyplexes [61], and lipoplexes [62].
3.4. Cellular uptake of LDH-DNA
We next investigated the cellular uptake of LDH-DNA com-
plexes, where DNA was predominantly adsorbed on the LDH NP
surface [48,59]. The loading capacity of DNA onto LDH was
determined by varying the LDH: DNAmass ratios, as discussed pre-
viously (Fig. 2). Based on the observations in Fig. 2, we chose two
LDH:DNA mass ratios, the first of which reflected incomplete
LDH-DNA complexation (5:1) while the second reflected complete
complexation (40:1), irrespective of NP size. The time-dependent
cellular uptake of both sets of LDH NPs with DNA-Cy3 is presented
in Fig. 6.
At the mass ratio of 5:1 (40 nM DNA-Cy3 and 1.4 lg/mL sLDH),
the percentage of Cy3-positive cells quickly increased to 60% after
just 2 h incubation, and then slowly increased to 80% over the next
6 h. However, in the case of L-LDH-DNA-Cy3, the percentage of
Cy3-positive cells increased steadily over the entire incubation
period, reaching a mere 20% after 8 h incubation (Fig. 6A). The
mean Cy3 fluorescence intensity followed a similar trend
(Fig. 6C). Our findings are consistent with our previous observation
in HEK-293T cells [49], suggesting that partial complexation of
DNA by L-LDH NPs at this mass ratio is detrimental to gene deliv-
ery efficiency. This observation seems to be similar to the report by
Elbakry et al. [63] that far more DNA molecules were delivered to
one cell by 20 nm Au NPs than 80 nm ones.
At the mass ratio of 40:1 (40 nM DNA-Cy3 and 11 lg/mL LDH),
treatment with sLDH and L-LDH led to a similar population of Cy3-
positive cells after 2 h of treatment. Prior to this time frame, a
higher percentage of Cy3 positive cells was seen with sLDH
(Fig. 6B). The mean Cy3 fluorescence intensity of cells treated with
sLDHwas twice that of cells treated with L-LDH after 1–8 h of incu-
bation (Fig. 6D), which indicates that sLDH is able to transport
twice the load of DNA as L-LDH, at this mass ratio. This observation
appears to be consistent with the following reports: more rapid
internalisation of smaller DNA/PEI complexes by K562 cells [64],
and smaller PLGA NPs by COS-7 and HEK-293 cells [65].
4. Discussion
The ease by which therapeutic nanoparticles (e.g. gene-carrier
systems) are taken up by their target cell population will directlyFig. 6. Time course cellular uptake of LDH-DNA-Cy3 by HCT-116 cells.
Fig. 7. Replot of normalised particle number concentration and particle number
taken up by cells based on the data in Fig. 3, including sLDH and L-LDH.
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‘efficiency’, such as the rate and intensity of transfection/fluores-
cence measured across a population of cells. With this in mind,
the key concepts underlying this work presented here aimed to
explore and decipher the effects of the LDH particle size, LDH
particle number concentration and dye/gene loading by LDH on
cellular delivery efficiency, using sLDH and L-LDH as our key NP
comparators.
4.1. Effect of LDH-NP size on cellular delivery efficiency
To specifically examine the effect of LDH particle size on deliv-
ery efficiency, we fixed the particle number concentration of either
sLDH or L-LDH particles. Since each L-LDH-FITC particle (90 nm) is
about 5 times (903/543 = 4.6) larger from a volume perspective
than each sLDH-FITC particle (54 nm), we employed 4 lg/mL
sLDH-5%FITC and 20 lg/mL L-LDH-1%FITC to ensure the presence
of a similar particle number concentration alongside an identical
load of FITC in each LDH particle. In such a cellular uptake test,
the FITC fluorescence intensity observed for each NP type when
delivered to a population of cells directly reflects the impact of
the particle size on uptake by HCT-116 cells.
Under these ‘identical’ conditions, HCT-116 cells were shown to
internalise a similar amount of FITC irrespective of whether the
vector being used was sLDH or L-LDH (Fig. 5). The only subtle dif-
ference was that the cellular uptake of sLDH NPs was seen to be
complete in the first 2 h, while L-LDH NPs showed a steady and
continual uptake over up to 8 h. Thus, this work shows that the
rate of cellular uptake in terms of the particle number was compa-
rable for the 54 nm (sLDH) and 90 nm (L-LDH) NPs. It is reported
that internalisation of NPs less than 200 nm involves the clath-
rin-mediated endocytotic pathway [17,18,66,67]; thus sLDH-FITC
(54 nm) and L-LDH-FITC (90 nm) used in this work entered
HCT-116 cells through the same pathway. That would be the rea-
son why sLDH-FITC and L-LDH-FITC resulted in similar uptake
regardless of the particle size difference. This result is consistent
with recent in vitro and in silico correlation studies where NPs
ranging in size from 50 to 100 nmwere found to be optimal for cel-
lular delivery [34]. It is also in partial agreement with a cluster of
earlier studies where ca. 50 nm NPs were more efficiently interna-
lised by a range of cell types [6,46].
Clearly, the cellular uptake rate of L-LDH from the particle
‘mass’ perspective is about 5 times that of sLDH as the volume of
one L-LDH particle is nearly 5 times that of one sLDH particle. This
translates to the fact that if sLDH-5%FTIC and L-LDH-5%FITC NPs
are delivered at an equivalent particle number concentration in
cellular uptake studies, the mean FITC fluorescence intensity of
HCT 116 cells treated by L-LDH-5%FITC would be expectedly 5
times that treated by sLDH-5%FTIC, which is really shown by the
data in Fig. 3. The mean fluorescence intensity of cells treated with
10.0–20.0 lg/mL of L-LDH-5%FITC was truly about 5 times that of
cells treated with 2.5–5.0 lg/mL of sLDH-5%FITC, where the parti-
cle number concentration in the two cases was approximately the
same.
4.2. Effect of the LDH particle number concentration on cellular
delivery efficiency
As shown in Fig. 3C, the amount of FITC delivered by sLDH
remained largely unchanged at mass doses P5.0 lg/mL, while it
increased substantially at the lower mass dose range of 1.4–
5.0 lg/mL. Similarly, the amount of FITC delivered by L-LDH
increased steadily at a mass dose from 1.4 to 20.0 lg/mL while
the increase was minimal from 10.0 to 20.0 lg/mL. It appears that
cellular uptake of NPs is dose dependent below a critical mass
concentration, while cellular uptake of NPs reaches a plateau ator beyond the critical mass concentration. In the current two cases,
the critical mass concentration of sLDH and L-LDH is in the region
of 5 and 20 lg/mL, respectively. Interestingly, the corresponding
critical particle number concentration in these two cases is very
similar, at approximately 1.0  1010 number/mL, which is also sup-
ported by the data shown in Fig. 7. The uptake curves are quite
similar for sLDH and L-LDH NPs, with a similar critical particle
number concentration. Clearly, cellular uptake in terms of the
LDH particle number is almost linearly dependent on the particle
number concentration below the critical number concentration
(1.0  1010 number/mL). Beyond this critical value, cellular uptake
does not improve. Chithrani et al. [6] have also reported dose-
dependent phenomena, and moreover, their critical NP number
concentration was estimated to be 0.3  1010 number/mL for
50 nm Au NPs based on the data provided, which is in close agree-
ment with our critical number concentration. Of course, the critical
number concentration of NPs could also be dependent on the cell
type and confluency.
As depicted in Fig. 4D, the amount of FITC delivered by L-LDH
was approximately twice that of sLDH after incubation for 1–8 h
at the same mass concentration (10 lg/mL). From this we can infer
that sLDH particle numbers taken up by HCT-116 cells was about
2.5 times that of L-LDH, although the number concentration of
sLDH particles was 5 times that of L-LDH particles. This uptake rate
of sLDH in terms of the particle number is less than that expected
(5 times), which could be due to the fact that the mass concentra-
tion of sLDH (10 lg/mL) is beyond the critical mass concentration
value (5 lg/mL) while that of L-LDH is below. Therefore, the rate of
cellular uptake of L-LDH is relatively slower in this instance.4.3. Effect of surface/internal-bulk loading on cellular delivery
efficiency
The cellular delivery efficiency can be also determined by the
manner of loading on/into the respective NPs. For example, the
amount of DNA-Cy3 delivered by sLDHs was 2–3 times that deliv-
ered by L-LDH (Fig. 6D). This is in sharp contrast to the results in
Fig. 4D where the amount of FITC delivered by sLDH was 2 times
less than that delivered by L-LDH, which reflects the impact of
loading style. It is important to note that DNA was loaded onto
LDH in a manner different from FITC, where FITC was intercalated
between the interlayers (bulk way), but DNA predominantly
adsorbed onto the surface of LDH NPs (surface way). Due to the dif-
ferences in loading sites on the NP, FITC loading could be controlled
through percentage of interlayer anion exchange and correlated
with the LDH NP volume, while DNA loading amount was corre-
lated with the LDH surface area.
At the equivalent mass concentration, sLDH with the Z-average
size of 40 nm has a surface area 2.5 times that of L-LDH with the
Z-average diameter size of 100 nm. From a loading perspective,
16 H. Dong et al. / Journal of Colloid and Interface Science 437 (2015) 10–16this means that sLDH is able to carry 2.5 times the load of DNA as
that of L-LDH, at the equivalent mass concentration. This may
explain why sLDH bound almost all DNA at the LDH:DNA mass
ratio of 2:1 (Fig. 2A), while a mass ratio of 5:1 was necessary in
the case of L-LDH (Fig. 2C). This may further reflect that the contri-
bution of unassociated DNA at the mass ratio of 5:1 was much
lower from sLDH (10%) than from L-LDH (50%) in the culture
media (Fig. 2B and D). Cebrián et al. [68] also found 6 nm
PEI-coated Au NPs can load higher quantities of DNA than equiva-
lent mass of 70 nm Au-PEI NPs because of the larger external sur-
face area per unit mass. The incomplete complexation of DNA-Cy3
observed with L-LDH at 5:1 in culture media would be expected to
reduce the cellular delivery of DNA-Cy3 to 50% of that using sLDH
at the same particle number concentration.
Aside from the effect of incomplete complexation, the observed
difference in the delivery efficiency of DNA-Cy3 may largely be
attributed to LDH particle number concentration changes. Here,
as the L-LDH particle number concentration (1.4 and 11 lg/mL)
was well below the critical value, cellular uptake of DNA-Cy3
would increase in proportion to the particle number concentration.
In comparison, sLDH NP number concentration at 1.4 lg/mL is
below the critical value while 11 lg/mL is well over the critical
value, so cellular uptake would increase less than in a proportional
manner. This understanding, together with the loading yield, goes
some way towards explaining why the amount of DNA-Cy3 deliv-
ered by sLDH was 10–15 times higher than that of L-LDH at the
mass ratio of 5:1, decreasing to about 2–3 times higher at the mass
ratio of 40:1 (Fig. 6C and D).
5. Conclusions
The cellular uptake of LDH NPs is highly dependent on its par-
ticle number concentration regardless of particle size in the range
of 40–100 nm. Under the critical particle number concentration,
cellular uptake was in linear proportion to the particle number
concentration, while above this critical value, the cellular uptake
was not further improved. This research further found that the size
of sheet-like LDH particles in the range of 40–100 nm could not
significantly affect the cellular uptake in terms of the particle num-
ber, and that the surface loading capacity of LDH NPs may signifi-
cantly affect the delivery efficiency.
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